Primary aldosteronism treatment response was associated with higher plasma renin activity and serum potassium levels and lower aldosterone.

During the open-label run-in period, patients underwent spironolactone titration, with a target to 50 mg/daily, and those with hyperkalemia started SZC. Patients with normokalemia (potassium 3.5-5 ...